Sanofi (SNY) News Today $48.22 -1.19 (-2.41%) Closing price 06/17/2025 04:00 PM EasternExtended Trading$48.40 +0.19 (+0.38%) As of 06/17/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why is Sanofi Down Today?Sanofi (NASDAQ: SNY) shares are experiencing mixed pressures from recent analyst upgrades, positive clinical data, financing news and legal developments. Bank of America Securities reiterated a Buy rating on Sanofi and set a €123.00 price target, citing promising amlitelimab Phase III trial results and strong competitive positioning. Zacks Research raised its Q1 2026 EPS estimate for Sanofi to $1.07 from $1.01 and lifted full-year 2026 earnings forecasts to $4.71 per share, reflecting improved revenue visibility. At the EAACI congress, Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma, reinforcing the drug’s market potential. Sanofi successfully priced a €1.5 billion bond offering split between a 2.625% 2029 tranche and a 3.000% 2032 tranche, strengthening its debt profile. A Zacks commentary highlighted Sanofi among five large-cap drug stocks well-positioned to benefit from a sector recovery, underlining solid industry fundamentals. Pomerantz LLP launched an investor class action investigation into Sanofi, raising concerns over potential litigation costs and reputational risk. The Schall Law Firm announced an opportunity for investors to join a fraud investigation against Sanofi, adding to ongoing legal scrutiny. Posted 5h agoAI Generated. May Contain Errors. SNY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Sanofi: Sanofi successfully prices €1.5 billion bond issueJune 17 at 10:58 AM | finanznachrichten.deINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNYJune 17 at 10:00 AM | prnewswire.comPress release: Sanofi successfully prices €1.5 billion bond issueJune 17 at 7:40 AM | globenewswire.comBuy Rating for Sanofi Driven by Promising Amlitelimab Phase III Trials and Competitive PositioningJune 17 at 6:32 AM | tipranks.comZacks Research Estimates Sanofi's Q1 Earnings (NASDAQ:SNY)June 17 at 1:21 AM | americanbankingnews.comSNY Investors Have Opportunity to Join Sanofi Fraud Investigation with the Schall Law FirmJune 16 at 7:03 PM | businesswire.comSanofi: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented ...June 16 at 8:21 AM | finanznachrichten.deDynamic Advisor Solutions LLC Invests $3.10 Million in Sanofi (NASDAQ:SNY)Dynamic Advisor Solutions LLC acquired a new stake in Sanofi (NASDAQ:SNY - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The fund acquired 55,837 shares of the company's stock, valued at approximately $3,097,000. A number of other large investors have also boughJune 16 at 4:39 AM | marketbeat.comSanofi (NASDAQ:SNY) Stake Lifted by SG Americas Securities LLCSG Americas Securities LLC raised its stake in Sanofi (NASDAQ:SNY - Free Report) by 57.8% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 28,411 shares of the company's stock after buying an additional 10,403 shares during the quarter. SG Americas SecuJune 16 at 3:48 AM | marketbeat.comZacks Research Issues Positive Estimate for Sanofi EarningsSanofi (NASDAQ:SNY - Free Report) - Equities researchers at Zacks Research increased their Q1 2026 EPS estimates for Sanofi in a research report issued on Thursday, June 12th. Zacks Research analyst K. Shah now forecasts that the company will earn $1.07 per share for the quarter, up from their prJune 16 at 1:35 AM | marketbeat.comRegeneron and Sanofi Announce Dupixent Outperformance over Xolair in Phase 4 EVEREST Trial Results for CRSwNP and AsthmaJune 15 at 11:42 AM | quiverquant.comPress Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory studyJune 15 at 11:22 AM | globenewswire.comBayBridge Capital Group LLC Buys Shares of 25,269 Sanofi (NASDAQ:SNY)BayBridge Capital Group LLC bought a new stake in Sanofi (NASDAQ:SNY - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 25,269 shares of the company's stock, valued at approximately $1,401,000. Several otJune 15 at 7:43 AM | marketbeat.comSound Income Strategies LLC Buys 6,073 Shares of Sanofi (NASDAQ:SNY)Sound Income Strategies LLC boosted its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 9.0% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 73,420 shares of the company's stock after buying an additional 6,073 shares during the quarteJune 15 at 7:21 AM | marketbeat.comBerenberg Bank Remains a Buy on Sanofi (SNY), Sets a €118 Price TargetJune 15 at 6:43 AM | insidermonkey.comSanofi (NASDAQ:SNY) Shares Bought by Willis Investment CounselWillis Investment Counsel grew its holdings in Sanofi (NASDAQ:SNY - Free Report) by 36.0% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 320,600 shares of the company's stock after acquiring an additional 84,900 shares during the quarter. WJune 13, 2025 | marketbeat.comAnalysts Can't Get Enough of These Little-Known Biopharma Stocks (SNY)Three relatively unknown biopharma firms receive near-unanimous approval from analysts for their promising drug candidates in development.June 12, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNYJune 12, 2025 | prnewswire.comSanofi (NASDAQ:SNY) Shares Purchased by Baker Ellis Asset Management LLCBaker Ellis Asset Management LLC raised its stake in Sanofi (NASDAQ:SNY - Free Report) by 7.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 93,780 shares of the company's stock after purchasing an additional 6June 11, 2025 | marketbeat.comSanofi (SNY) Presents at Goldman Sachs 46th Annual Global Healthcare Conference TranscriptJune 10, 2025 | seekingalpha.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNYJune 10, 2025 | globenewswire.comMerck’s RSV shot for infants cleared in U.S., challenging Sanofi/Astra’s dominanceJune 10, 2025 | msn.comPark Avenue Securities LLC Has $3.08 Million Stock Position in Sanofi (NASDAQ:SNY)Park Avenue Securities LLC cut its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 19.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 55,543 shares of the company's stock after selling 13,439 shares during theJune 10, 2025 | marketbeat.comOLD National Bancorp IN Sells 6,722 Shares of Sanofi (NASDAQ:SNY)OLD National Bancorp IN lessened its stake in Sanofi (NASDAQ:SNY - Free Report) by 27.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 17,651 shares of the company's stock after selling 6,722 shares during thJune 10, 2025 | marketbeat.comFDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstaZenecaJune 9, 2025 | cnbc.comSanofi (SNY) Accelerates Beyfortus Distribution for RSV SeasonJune 9, 2025 | gurufocus.comBeyfortus Output Tripled As Sanofi, AstraZeneca Scale Up For RSV SeasonJune 9, 2025 | benzinga.comFoundation Resource Management Inc. Sells 11,605 Shares of Sanofi (NASDAQ:SNY)Foundation Resource Management Inc. trimmed its holdings in Sanofi (NASDAQ:SNY - Free Report) by 4.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 260,662 shares of the company's stock after selling 11,605 shares during theJune 9, 2025 | marketbeat.comSanofi speeds up Beyfortus shipping ahead of 2025-2026 RSV seasonJune 9, 2025 | msn.comSanofi (SNY) Expands Beyfortus Production Ahead of RSV SeasonJune 9, 2025 | gurufocus.comRegeneron, Sanofi presents results from DISCOVER Phase 4 trial of DupixentJune 8, 2025 | msn.comRegeneron and Sanofi Announce Positive DISCOVER Trial Results for Dupixent in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis in Communities of ColorJune 7, 2025 | quiverquant.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNYJune 7, 2025 | prnewswire.comMerit Financial Group LLC Purchases 7,054 Shares of Sanofi (NASDAQ:SNY)Merit Financial Group LLC increased its position in Sanofi (NASDAQ:SNY - Free Report) by 33.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 27,848 shares of the company's stock after purchasing an additiJune 7, 2025 | marketbeat.comSanofi (SNY) Stock Down 5% Despite AERIFY-1 SuccessJune 6, 2025 | insidermonkey.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNYJune 6, 2025 | globenewswire.comGAMMA Investing LLC Grows Holdings in Sanofi (NASDAQ:SNY)GAMMA Investing LLC grew its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 8,703.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 335,921 shares of the company's stock after buying an aJune 6, 2025 | marketbeat.comVigil Neuroscience: ALSP Data Doesn't Deliver, But Sanofi Purchase Remains IntactJune 5, 2025 | seekingalpha.comSanofi (SNY) Takes Bold $9.5Bn Immunology LeapJune 5, 2025 | tipranks.comPress release: Sanofi Launches 2025 Global Employee Stock Purchase PlanJune 5, 2025 | globenewswire.comSanofi’s Strategic Acquisition of Blueprint Medicines: A Boost to Rare Disease Portfolio and Long-term GrowthJune 5, 2025 | tipranks.comRichard P Slaughter Associates Inc Sells 26,532 Shares of Sanofi (NASDAQ:SNY)Richard P Slaughter Associates Inc lessened its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 86.9% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,985 shares of the company's stock after selling 26,532 shareJune 4, 2025 | marketbeat.comContravisory Investment Management Inc. Makes New Investment in Sanofi (NASDAQ:SNY)Contravisory Investment Management Inc. acquired a new position in Sanofi (NASDAQ:SNY - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 16,960 shares of the company's stock, valued at approximately $941,000. Several otJune 4, 2025 | marketbeat.comBlueprint Medicines (BPMC) Sees Upgrade and Acquisition by Sanofi | BPMC Stock NewsJune 4, 2025 | gurufocus.comWealth Enhancement Advisory Services LLC Has $3.59 Million Stake in Sanofi (NASDAQ:SNY)Wealth Enhancement Advisory Services LLC raised its holdings in Sanofi (NASDAQ:SNY - Free Report) by 40.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 74,362 shares of the company's stock after acquirJune 4, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Receives Consensus Recommendation of "Buy" from AnalystsShares of Sanofi (NASDAQ:SNY - Get Free Report) have been assigned an average rating of "Buy" from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and three have issuJune 4, 2025 | marketbeat.comStifel Maintains Buy Rating on Nurix (NRIX) StockJune 3, 2025 | insidermonkey.comSanofi to Buy Blueprint Medicines for Up to $9.5 Billion in Boost to PipelineJune 3, 2025 | wsj.comMorgan Stanley Resumes Sanofi (SNY) Coverage, Assigns Equal Weight RatingJune 3, 2025 | insidermonkey.comPress Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injectorJune 3, 2025 | globenewswire.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address SNY Media Mentions By Week SNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNY News Sentiment▼0.950.90▲Average Medical News Sentiment SNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNY Articles This Week▼2317▲SNY Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVO News NVS News AZN News GSK News TAK News ARGX News ONC News BNTX News TEVA News SMMT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNY) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhat 99% of investors are missing about Chinese AIChinese AI chatbot DeepSeek's release put the spotlight on AI and turned the tech world on its head. But 99...Weiss Ratings | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNY Stock Free SNY Stock Alerts